Xilio Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Xilio Therapeutics

07/11/2024 14:09

* Xilio Therapeutics Inc  XLO.OQ   XLO.O  is expected
to show a
rise in quarterly revenue when it reports  results on November 9
(estimated) for the period ending September 30 2024
    * The Waltham Massachusetts-based  company is expected to
report
revenue of $3.3 million, according to the mean estimate from 2
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Xilio Therapeutics Inc
is for
a loss of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Xilio
Therapeutics Inc is 5.50​, above​ its last closing price
of $1.29. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.30       -0.23      -0.24     Missed  -4.3
 Mar. 31 2024  -0.16       -0.11      -0.62     Missed  -463.6
 Dec. 31 2023  -0.64       -0.64      -0.64     Met     0​
 Jan. 1 0001   -0.77       -0.81      -0.61     Beat    24.5
 ​​Jun.        -0.83       -0.87      -0.70     Beat    19.3
 30 2023                                                
 Mar. 31 2023  -0.87       -0.89      -0.83     Beat    6.3​
 Dec. 31 2022  -0.78       -0.78      -0.82     Missed  -4.5
 Sep. 30 2022  -0.88       -0.88      -0.72     Beat    17.9
 This summary was machine generated November 7 at 14:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)